TRADE NEWS: Agilent Technologies Appoints Turku Centre for Biotechnology of University of Turku as Certified Service Provider for Gene Expression Microarrays

Agilent Technologies Inc. (NYSE:A) today announced that the Turku Centre for Biotechnology of University of Turku and Abo Akademi University has achieved Certified Service Provider status for Agilent gene expression microarrays. The Centre achieved Agilent-certified status after completing training and passing a rigorous series of assessments that include: -- demonstrating proficiency in analyzing Agilent's 60-mer [...]

Multi-National Oil and Gas Company Chooses Accelrys to Increase Efficiency in Catalyst Discovery and Optimization

SAN DIEGO--Accelrys, Inc. (NASDAQ: ACCL - News), a leading provider of scientific business intelligence software and services, today announced that one of the largest multi-national oil and gas companies has chosen Accelrys to develop an integrated solution which would enable this company’s catalyst research scientists to both accelerate catalysis research and discovery and to improve [...]

Illumina Launches mRNA-Seq on the Genome Analyzer

Illumina, Inc. (NASDAQ:ILMN) today announced the broad availability of mRNA-Seq, a new product for full-length, complementary DNA (cDNA) sequencing on the Genome Analyzer. In contrast to tiling and exon arrays, researchers can use mRNA-Seq to obtain a more in-depth, comprehensive view of the transcriptome, revealing aspects previously unseen using array-based or expression sequence tag (EST) [...]

Roche NimbleGen Launches 2.1 Million-Probe Arrays for the Detection of Chromosomal Aberrations and DNA Copy Number Variation

Roche NimbleGen, a company of Roche announced today the launch of comparative genomic hybridization (CGH) arrays and services for the high-resolution mapping of genomic copy-number differences based on the company's new 2.1 million-probe HD2 platform. Roche NimbleGen's HD2 array platform greatly enhances the capability and resolution of CGH whole-genome analysis by providing a single array [...]

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

Illumina, Inc. (NASDAQ:ILMN) today announced that the Genome Institute of Singapore (GIS), a flagship institution of Singapore and one of the top research centers in the world, has purchased four additional Genome Analyzers taking its installed base to six. Among researchers at GIS, the Genome Analyzer continues to be the preferred platform for conducting sequencing [...]

Applied Biosystems/MDS Analytical Technologies Introduces Next-Generation Mass Spectrometry Systems

Applied Biosystems Inc. (NYSE:ABI) and its joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (NYSE:MDZ) (TSX:MDS), today announced the introduction of two of the most advanced mass spectrometry systems ever built - the AB SCIEX Triple Quad(TM) 5500 and the AB SCIEX QTRAP(R) 5500 Systems - both of which will provide researchers [...]

CLC bio Signs Strategic Collaborative Agreement with J. Craig Venter Institute

CLC bio, a world leading full-service bioinformatics solution provider announced today an agreement with the J. Craig Venter Institute, a not-for profit genomic-focused research institute. The accord consists of a multi-year site license for the entire CLC bio bioinformatics suite of products. The goal is to implement CLC bio's enterprise solution as a scientific platform [...]

Ludesi Appoints International Executive Lars Eric Utterman as New Chairman for Its Board of Directors

Ludesi Corporation, developer of the award-winning Ludesi Image Analysis Service and the Ludesi REDFIN software for two-dimensional electrophoresis gels, today announced the appointment of Lars Eric Utterman as the new chairman of Ludesi's Board of Directors. Mr. Utterman has a distinguished career in the biotechnology, diagnostics and pharmaceutical industries with more than 30 years experience [...]

Invitrogen Joins EPA’s Climate Leaders Program

As a part of its continued commitment to environmental sustainability, Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced its participation in the U.S. Environmental Protection Agency's (EPA's) Climate Leaders program. By participating in Climate Leaders, Invitrogen has pledged to reduce its corporate-wide greenhouse gas emissions. Climate [...]

Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing

Scripps Translational Science Institute, Navigenics, Affymetrix and Microsoft team on groundbreaking health study SAN DIEGO, Oct. 9 -- A consortium of health care, technology and research leaders have joined forces in a first-of-its-kind research study to assess the behavioral impact of personal genetic testing on people who choose to receive such screenings to identify their [...]

Access IBO on Knowledge Center